Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France

被引:0
作者
A. Bergal
L. Loucif
D. E. Benouareth
A. A. Bentorki
C. Abat
J.-M. Rolain
机构
[1] Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE),Facultés de Médecine et de Pharmacie
[2] UM63 CNRS 7278 IRD 198 INSERM U1905,Département d’Écologie et Génie de l’Environnement, Faculté des Sciences de la Nature et de la Vie et Sciences de la Terre et de l’Univers
[3] IHU Méditerranée Infection,Laboratoire de Biotechnologie des Molécules Bioactives et de la Physiopathologie Cellulaire (LBMBPC)
[4] Université 8 Mai 1945,Laboratoire de Microbiologie
[5] Université El Hadj Lakhdar,undefined
[6] CHU Dorban,undefined
来源
European Journal of Clinical Microbiology & Infectious Diseases | 2015年 / 34卷
关键词
Tetracycline Resistance; Multilocus Sequence Typing; tetM; Erythromycin Resistance; Streptococcus Agalactiae;
D O I
暂无
中图分类号
学科分类号
摘要
This study describes, for the first time, the genetic and phenotypic diversity among 93 Streptococcus agalactiae (group B Streptococcus, GBS) isolates collected from Guelma, Algeria and Marseille, France. All strains were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). The molecular support of antibiotic resistance and serotyping were investigated by polymerase chain reaction (PCR). The phylogenetic lineage of each GBS isolate was determined by multilocus sequence typing (MLST) and grouped into clonal complexes (CCs) using eBURST. The isolates represented 37 sequence types (STs), 16 of which were novel, grouped into five CCs, and belonging to seven serotypes. Serotype V was the most prevalent serotype in our collection (44.1 %). GBS isolates of each serotype were distributed among multiple CCs, including cps III/CC19, cps V/CC1, cps Ia/CC23, cps II/CC10, and cps III/CC17. All isolates presented susceptibility to penicillin, whereas resistance to erythromycin was detected in 40 % and tetracycline in 82.2 % of isolates. Of the 37 erythromycin-resistant isolates, 75.7 % showed the macrolide–lincosamide–streptogramin B (MLSB)-resistant phenotype and 24.3 % exhibited the macrolide (M)-resistant phenotype. Constitutive MLSB resistance (46 %) mediated by the ermB gene was significantly associated with the Guelma isolates, whereas the M resistance phenotype (24.3 %) mediated by the mefA/E gene dominated among the Marseille isolates and belonged to ST-23. Tetracycline resistance was predominantly due to tetM, which was detected alone (95.1 %) or associated with tetO (3.7 %). These results provide epidemiological data in these regions that establish a basis for monitoring increased resistance to erythromycin and also provide insight into correlations among clones, serotypes, and resistance genes.
引用
收藏
页码:2339 / 2348
页数:9
相关论文
共 372 条
  • [1] Wang NY(2014)Group B streptococcal serine-rich repeat proteins promote interaction with fibrinogen and vaginal colonization J Infect Dis 210 982-991
  • [2] Patras KA(2013)Commensal BMC Microbiol 13 297-205
  • [3] Seo HS(2013) isolated from patients seen at University Hospital of Londrina, Paraná, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinants J Perinatol 33 198-92
  • [4] Cavaco CK(2009)Neonatal early-onset sepsis evaluations among well-appearing infants: projected impact of changes in CDC GBS guidelines Clin Infect Dis 49 85-584
  • [5] Rösler B(2015)Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990–2007 Eur J Clin Microbiol Infect Dis 34 579-434
  • [6] Neely MN(2011)Antimicrobial susceptibility profiles, serotype distribution and virulence determinants among invasive, non-invasive and colonizing J Microbiol Immunol Infect 44 430-797
  • [7] Sullam PM(2003) (group B streptococcus) from Malaysian patients Antimicrob Agents Chemother 47 794-235
  • [8] Doran KS(2011)Multilocus sequence typing of invasive group B J Med Microbiol 60 230-592
  • [9] Otaguiri ES(2010) in central area of Taiwan Int J Antimicrob Agents 35 590-1576
  • [10] Morguette AE(2002)Genetic basis of antibiotic resistance in Antimicrob Agents Chemother 46 1574-223